Sarepta Therapeutics, Inc. Insider Trading for March 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sarepta Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Sarepta Therapeutics, Inc. for March 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Chief Regulato ... | Option Exercise | M | 26.24 | 2,031 | 53,293 | 10,066 | |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Chief Regulato ... | Option Exercise | M | 13.90 | 469 | 6,519 | 6,134 | |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Chief Regulato ... | Payment of Exercise | F | 81.22 | 656 | 53,280 | 28,809 | 29.5 K to 28.8 K (-2.23 %) |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Chief Regulato ... | Buy | M | 26.24 | 2,031 | 53,293 | 29,465 | 27.4 K to 29.5 K (+7.40 %) |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Chief Regulato ... | Payment of Exercise | F | 81.22 | 80 | 6,498 | 27,434 | 27.5 K to 27.4 K (-0.29 %) |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Chief Regulato ... | Buy | M | 13.90 | 469 | 6,519 | 27,514 | 27 K to 27.5 K (+1.73 %) |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | M | 23.85 | 2,074 | 49,465 | 13,018 | |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | M | 13.90 | 403 | 5,602 | 5,590 | |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | M | 13.71 | 23 | 315 | 70 | |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Payment of Exercise | F | 81.22 | 609 | 49,463 | 31,118 | 31.7 K to 31.1 K (-1.92 %) |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Buy | M | 23.85 | 2,074 | 49,465 | 31,727 | 29.7 K to 31.7 K (+6.99 %) |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Payment of Exercise | F | 81.22 | 68 | 5,523 | 29,653 | 29.7 K to 29.7 K (-0.23 %) |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Buy | M | 13.90 | 403 | 5,602 | 29,721 | 29.3 K to 29.7 K (+1.37 %) |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Payment of Exercise | F | 81.22 | 3 | 244 | 29,318 | 29.3 K to 29.3 K (-0.01 %) |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Buy | M | 13.71 | 23 | 315 | 29,321 | 29.3 K to 29.3 K (+0.08 %) |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | M | 26.24 | 1,370 | 35,949 | 11,415 | |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | M | 13.90 | 835 | 11,607 | 5,001 | |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | M | 13.71 | 54 | 740 | 6,107 | |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | M | 13.71 | 241 | 3,304 | 1,485 | |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Payment of Exercise | F | 81.22 | 442 | 35,899 | 25,325 | 25.8 K to 25.3 K (-1.72 %) |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Buy | M | 26.24 | 1,370 | 35,949 | 25,767 | 24.4 K to 25.8 K (+5.62 %) |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Payment of Exercise | F | 81.22 | 142 | 11,533 | 24,397 | 24.5 K to 24.4 K (-0.58 %) |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Buy | M | 13.90 | 835 | 11,607 | 24,539 | 23.7 K to 24.5 K (+3.52 %) |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Payment of Exercise | F | 81.22 | 9 | 731 | 23,704 | 23.7 K to 23.7 K (-0.04 %) |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Buy | M | 13.71 | 54 | 740 | 23,713 | 23.7 K to 23.7 K (+0.23 %) |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Payment of Exercise | F | 81.22 | 40 | 3,249 | 23,659 | 23.7 K to 23.7 K (-0.17 %) |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Buy | M | 13.71 | 241 | 3,304 | 23,699 | 23.5 K to 23.7 K (+1.03 %) |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 23.85 | 2,500 | 59,625 | 11,768 | |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Payment of Exercise | F | 81.22 | 734 | 59,615 | 42,661 | 43.4 K to 42.7 K (-1.69 %) |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 23.85 | 2,500 | 59,625 | 43,395 | 40.9 K to 43.4 K (+6.11 %) |
| Mar 07 2018 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Option Exercise | A | 71.45 | 4,820 | 344,389 | 4,820 | |
| Mar 07 2018 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Grant | A | 0.00 | 3,418 | 0 | 10,084 | 6.7 K to 10.1 K (+51.28 %) |
| Mar 07 2018 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Chief Regulato ... | Option Exercise | A | 71.45 | 70,000 | 5,001,500 | 70,000 | |
| Mar 07 2018 | SRPT | Sarepta Therapeuti ... | Nicaise Claude | Director | Option Exercise | A | 71.45 | 4,820 | 344,389 | 4,820 | |
| Mar 07 2018 | SRPT | Sarepta Therapeuti ... | Nicaise Claude | Director | Grant | A | 0.00 | 3,418 | 0 | 5,418 | 2 K to 5.4 K (+170.90 %) |
| Mar 07 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | A | 71.45 | 97,500 | 6,966,375 | 97,500 | |
| Mar 07 2018 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | A | 71.45 | 70,000 | 5,001,500 | 70,000 | |
| Mar 07 2018 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | A | 71.45 | 70,000 | 5,001,500 | 70,000 | |
| Mar 07 2018 | SRPT | Sarepta Therapeuti ... | BONNEY MICHAEL W | Director | Option Exercise | A | 71.45 | 4,820 | 344,389 | 4,820 | |
| Mar 07 2018 | SRPT | Sarepta Therapeuti ... | BONNEY MICHAEL W | Director | Grant | A | 0.00 | 3,418 | 0 | 3,418 | 0 to 3.4 K |
| Mar 07 2018 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Option Exercise | A | 71.45 | 4,820 | 344,389 | 4,820 | |
| Mar 07 2018 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Grant | A | 0.00 | 3,418 | 0 | 116,534 | 113.1 K to 116.5 K (+3.02 %) |
| Mar 07 2018 | SRPT | Sarepta Therapeuti ... | Basi Guriqbal S. | SVP, Chief Scientif ... | Option Exercise | A | 71.45 | 70,000 | 5,001,500 | 70,000 | |
| Mar 07 2018 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Option Exercise | A | 71.45 | 4,820 | 344,389 | 4,820 | |
| Mar 07 2018 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Grant | A | 0.00 | 3,418 | 0 | 3,245,432 | 3.2 M to 3.2 M (+0.11 %) |